Biocon may gain after agreement with CMS

Biocon said it has signed a license and supply agreement with a subsidiary of China Medical System Holdings for three generic formulation products in Greater China. As part of the agreement, Biocon will be responsible for the development, manufacturing and supply of the products, while CMS will be responsible for registration and commercialisation of the products in China. The announcement was made after market hours yesterday, 12 September 2019.

Dr Reddy's Laboratories said that the company has received an EIR from the US FDA indicating closure of this audit of its formulations manufacturing plants at Duvvada, Visakhapatnam, which was completed on 21 June 2019. The announcement was made after market hours yesterday, 12 September 2019.

L&T Finance Holdings said that the meeting of the Board of Directors of the company is scheduled on 17 September 2019, to consider and approve raising of funds through proposed issue aggregating up to Rs 150 crore and determine the issue price. The announcement was made after market hours yesterday, 12 September 2019.

Dewan Housing Finance Corporation informed that the company has defaulted on payment of interest & principal on Non-Convertible Debentures (NCDs) worth Rs 196.65 crore. The announcement was made after market hours yesterday, 12 September 2019.

Gravita India informed that Recyclers Ghana, a step down subsidiary of the company situated in Ghana, West Africa has enhanced the production capacity of its existing Lead Recycling Plant from 6,000 MTPA to 12,000 MTPA. The announcement was made after market hours yesterday, 12 September 2019.

Powered by Capital Market - Live News